Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03547453 · ClinicalTrials.gov registry record
Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome
A clinical trial, sponsored by Cornell University.
- Completed
- Registry status
- 240
- Enrollment target
NCT03547453 is a clinical trial that has completed, run by Cornell University. The registered enrollment target is 240 participants.
The verdict
NCT03547453 has completed, sponsored by Cornell University.
- COMPLETED
- Registry status
- 240 participants
- Enrollment target
Study Summary
The investigators would like to determine how aspects of adiposity and age influence ultrasound features of the ovaries which are used to diagnose polycystic ovarian syndrome (PCOS). The study will also compare anti-Müllerian hormone (AMH) levels against ultrasound features of the ovary to predict PCOS.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2018-06-04 |
| Est. Completion | 2022-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03547453
The ClinicalTrials.gov registry entry for NCT03547453 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cornell University, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03547453 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03547453 about?
NCT03547453 is a clinical study titled "Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome". The investigators would like to determine how aspects of adiposity and age influence ultrasound features of the ovaries which are used to diagnose polycystic ovarian syndrome (PCOS). The study will also compare anti-Müllerian hormone (AMH) levels against ultrasound features of the ovary to predict P...
What is the current status of trial NCT03547453?
This trial is currently completed. The enrollment target is 240 participants. The study started on 2018-06-04. Estimated completion is 2022-12-31.
Who is sponsoring clinical trial NCT03547453?
This trial is sponsored by Cornell University, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.